Publications > Journals > Journal of Clinical and Translational Hepatology > Special Feature

Time: March 24, 2021

Journal: Journal of Clinical and Translational Hepatology

Special Issue: Metabolic dysfunction-associated fatty liver disease (MAFLD)

Guest Editors: Prof. Ming-Hua Zheng 

Status: Close

Submission deadline: May 31, 2021

Publication date: An article will be published online as soon as it is accepted.

Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as Nonalcoholic Fatty Liver Disease (NAFLD), is recently proposed nomenclature with a new set of diagnostic criteria. With an estimated 2 billion people being affected around the world, MAFLD signifies a growing global health burden, and such health challenge is expected to grow in the coming decade and especially among demographics with higher rate of obesity. Currently, MAFLD is recognized to increase the risk for higher severity in patients with the COVID-19.

For this special issue, we invite front-line hepatologists and liver researchers to submit high-quality scientific manuscripts regarding MAFLD. Potential topics include, but are not limited to:

  • Diagnostics and biomarkers  
  • Epidemiology and natural history, prevention, outcomes  
  • Therapeutics  
  • Pediatric MAFLD  
  • MAFLD-related acute on chronic liver failure, hepatocellular carcinoma, COVID-19  
  • MAFLD and extrahepatic disease (e.g., celiac disease, inflammatory bowel disease, chronic obstructive pulmonary disease, chronic kidney disease, cardiovascular diseases)  
  • MAFLD vs. NAFLD 

The authors should refer to the Instructions for Authors in preparing the manuscript and kindly submit it through the Online Submission System directly.

Priority will be given with the same high standards of peer review and publication process for these articles. All publications will open free access to all readers. We guarantee that all accepted papers related to MAFLD will be highlighted in a special section on our website.

Guest Editors’ Profiles:


Ming-Hua Zheng, MD, PhD

Prof. Zheng is a Professor at NAFLD Research Center of the First Affiliated Hospital of Wenzhou Medical University. Prof. Zheng has founded the PERSONS platform and dedicated to the development of its infrastructure since December 7, 2016. PERSONS is the acronym for Prospective Epidemic Research Specifically of NASH.. The database is an ongoing prospective cohort consisting of more than 1300 cases of biopsy-proven NAFLD (2019-07-01) and supported by a multidisciplinary team. The team boasts its advantage in patient data collection across multiple fields of medicine including nutrition, sports, hepatology, endocrinology, cardiology, psychology, pathology, and radiology. The doctors in the team specialized in each of these fields contribute in a consistent manner to ensure continuity and steady growth of the database. Moreover, biobank including blood, urine, stool, pathology slides (digitized by scan), and liver tissue samples, is collected and stored in the same day of biopsy.

Online submission system:

Instructions for authors: Please state in a cover letter that the manuscript is being submitted for inclusion in the special issue ‘Metabolic dysfunction-associated fatty liver disease (MAFLD)’ and follow the usual JCTH instructions. Please refer to:

For any inquiries, please contact the journal by e-mail: [email protected]